Keyphrases
Adverse Events
11%
Alcohol Group
5%
Anxiety Symptoms
5%
Benzodiazepine Dependence
16%
Benzodiazepine Withdrawal
100%
Benzodiazepines
100%
Carbamazepine
5%
CINAHL
5%
Clinical Analysis
5%
Clinical Recommendations
5%
Cochrane
11%
Confidence Interval
100%
Drug Groups
5%
Embase
5%
Error Bias
5%
Extracted Data
5%
Flumazenil
16%
ISI Web of Science
5%
Limited number of Participants
5%
Long Follow-up
11%
Long-term Clinical Outcome
5%
Methodological Procedures
5%
Multiple Interventions
5%
Number of Trials
5%
Number-needed-to-treat
5%
Panic
5%
Paroxetine
16%
Patient-centered
5%
Pharmacological Intervention
100%
Pharmacological Treatment
11%
Placebo
5%
Potential Gains
5%
Pregabalin
11%
Prolonged Treatment
5%
Psychiatric Population
5%
PubMed
5%
Random Error
5%
Randomized Controlled Trial
16%
Risk of Bias
5%
Risk Ratio
38%
Short-term Use
5%
Standardized Mean Difference
5%
Systematic Error
5%
Tricyclic Antidepressants
11%
Valproate
11%
Withdrawal Syndrome
16%
Neuroscience
Benzodiazepine
100%
Benzodiazepine Dependence
9%
Carbamazepine
9%
Drug Therapy
9%
Flumazenil
27%
Paroxetine
27%
Placebo
9%
Pregabalin
18%
Randomized Controlled Trial
27%
Tricyclic Antidepressant
18%
Withdrawal Syndrome
27%
Pharmacology, Toxicology and Pharmaceutical Science
Alpidem
9%
Captodiamine
18%
Cyamemazine
9%
Magnesium Aspartate
9%